Global Market News

Pharma defeats biotech push for rapid approval program

2/2/2012

Biotechs butted heads with their far-larger pharmaceutical allies over a key lobbying issue, and lost. As Bloomberg reports, biotechnology companies threw their weight behind a plan drafted by North Carolina Democratic Sen. Kay Hagan to launch a more rapid FDA approval program, using fewer human trials, for orphan drugs or treatments that address fatal diseases. Pharmaceutical companies beat back the measure, however, apparently not wanting to dilute existing safety measures
 

Fierce BioTech



Return to Previous Page

Today Is:
Wednesday, October 01, 2014


October Events

<< >>
SMTWTFS
1234
567891011
12131415161718
19202122232425
262728293031